Myeloma Patients Europe AISBL
13.4 FTEMyeloma Patients Europe reported total assets of €1.73m at the end of the 2025 financial year (annual accounts filed with the NBB on 08 May 2026), with 13.4 full-time equivalents.
By total assets for 2025, Myeloma Patients Europe ranks in the top half of the 848 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Myeloma Patients Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +98 % Headcount (avg FTE) +28 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Myeloma Patients Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 May 2026
- Year ended 31 Dec 2024filed on 20 May 2025
- Year ended 31 Dec 2023filed on 08 May 2024
- Year ended 31 Dec 2022filed on 30 Aug 2024
Myeloma Patients Europe's financial analysis
- Solvency62.3%sector median: 44.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Myeloma Patients Europe
9 active director(s) in the register.
and 3 more
Myeloma Patients Europe's shareholders and holdings →Myeloma Patients Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0842.182.407
- VAT number
- BE0842182407
- Peppol
- Registered · 0208:0842182407 · as of 13 Nov 2026
- Legal form
- AISBL
- Incorporated
- 28 Dec 2011
- Registered office
- 1050 Ixelles
- Size
- Small · 13.4 FTE
- Latest accounts
- 2025 · filed on 08 May 2026
- Activity
- Activities of other associations n.e.c. (NACE 94999)
Myeloma Patients Europe (AISBL) has been based in Ixelles since 2011, active in: activities of other associations n.e.c.. For 2025, it reports a net profit of 154,630 € and equity of €1.08m; its revenue is not published. With 13.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 62.3%, above the median of its sector (44.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Myeloma Patients Europe
Companies in the same business, of comparable size and area, outside its group.
- Kenniscentrum Toerisme en Horeca Business and other management consultancy activities Bruges · balance sheet €1.22m
- Recydata Business and other management consultancy activities Wemmel · balance sheet €1.18m
- Migration Policy Group Business and other management consultancy activities Etterbeek · balance sheet €1.08m
- EMCC Global Business and other management consultancy activities Saint-Gilles · balance sheet €2.18m
- RCN Justice et Democratie Business and other management consultancy activities Brussels · balance sheet €3.01m
- European Citizen Action Service - Euro Citoyen Action et Services - Europa en Burger Actie en Service Business and other management consultancy activities Brussels · balance sheet €4.25m
- Centre Provincial Liégeois de Promotion et de Gestion en Agriculture Business and other management consultancy activities Waremme · balance sheet €1.61m
- De Cosmograaf Business and other management consultancy activities Ninove · balance sheet €1.50m
Frequently asked questions about Myeloma Patients Europe
What is the revenue of Myeloma Patients Europe?
Myeloma Patients Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Myeloma Patients Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0842182407 for Myeloma Patients Europe, if the company is VAT-registered. Its company number (CBE) is 0842.182.407.
Where is the registered office of Myeloma Patients Europe?
According to the CBE register, the registered office of Myeloma Patients Europe is in 1050 Ixelles.
What is the equity of Myeloma Patients Europe?
At the close of the 2025 financial year, the equity of Myeloma Patients Europe amounts to 1,076,767 €, a solvency of 62.3% of total assets.
How many people work at Myeloma Patients Europe?
13.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Myeloma Patients Europe?
The register lists 9 active mandates at Myeloma Patients Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Myeloma Patients Europe within its sector?
By total assets for 2025, Myeloma Patients Europe ranks in the top half of the 848 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year.
The full file of Myeloma Patients Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →